Skip to main content
September 22, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them.
September 13, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD). 
September 11, 2019
Anthony L. Rostain, MD, MA, discusses steps to take when treating attention-deficit/hyperactivity disorder (ADHD) in patients with hypertension or cardiovascular disease.
September 05, 2019
Anthony L. Rostain, MD, MA, discusses factors to consider when combining stimulants and nonstimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD). 
August 26, 2019
When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his thoughts in this video.
August 13, 2019
Anthony L. Rostain, MD, MA, discusses the differences between diagnosing attention-deficit/hyperactivity disorder (ADHD) in adults and diagnosing it in children.
April 10, 2019
Presented by: Stephen V Faraone, PhD, Distinguished Professor of Psychiatry and of Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, NY. Sponsored by Arbor Pharmaceuticals, LLC.
May 18, 2018
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses why bipolar disorder is often misdiagnosed, differentiating bipolar disorder from depression and attention-deficit/hyperactivity disorder, and signs of disruptive mood dysregulation disorder.
August 15, 2014
Timothy Wilens MD, Associate Professor of Psychiatry at Harvard Medical School, explains his three tips for practitioners who regularly prescribe stimulants to older adolescents, college age students, and individuals with histories of substance abuse.
March 07, 2014
Timothy Wilens, MD, discusses new research that clarifies whether ADHD medications have neurotoxic, neuroprotective, or neutral effects on the developing brain.
Back to Top